Journal article icon

Journal article

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS Trial.

Abstract:

Objective

Type 2 diabetes is associated with increased fracture risk, further elevated by treatments such as thiazolidinediones and sodium-glucose co-transporter-2 inhibitors. As data regarding dipeptidyl peptidase-4 inhibitors are mixed, we examined fracture incidence in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Research Design and Methods

We used data from 14,671 TECOS patients randomized double-blind to sitagliptin (n=7332) or place...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1111/dom.12786

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
OCDEM
Role:
Author
Expand authors...
Merck and Co., Inc More from this funder
Publisher:
Wiley Publisher's website
Journal:
Diabetes, Obesity and Metabolism Journal website
Volume:
19
Issue:
1
Pages:
78-86
Publication date:
2016-09-01
Acceptance date:
2016-09-05
DOI:
EISSN:
1463-1326
ISSN:
1462-8902
Pmid:
27607571
Source identifiers:
641869
Language:
English
Keywords:
Pubs id:
pubs:641869
UUID:
uuid:ce57bb83-a809-495f-979a-0837881a4adc
Local pid:
pubs:641869
Deposit date:
2017-05-30

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP